D-758
Salidroside Determination by HPLC using Uv-Vis Spectroscopy
Original Document
Scanned document (image-only PDF)
Extracted Text
Searchable text extracted from PDF
1.0 Purpose The purpose of this procedure is to define the method for the quantitation and/or identification of salidroside in raw materials and finished product dietary supplements using HPLC and UV/VIS spectrophotometry. 2.0 Scope This procedure applies to the quantification and identification of salidroside in raw materials and finished products. Salidroside is a good chromophore and was measured at 205, other wavelengths should not be used without justification. 3.0 Responsibility 3.1 It is the responsibility of QC Chemists to follow this procedure. 3.2 It is the responsibility of the QC Laboratory Management to ensure that this procedure is being followed. 3.3. It is the responsibility of the QC Laboratory and Analytical Development Management to keep this procedure aligned with current practices. 4.0 Definitions 4.1 HPLC — High Performance Liquid Chromatography 4.2 UV/VIS — Ultraviolet and Visible Electromagnetic Spectrums 4.3. HsPQs4-—- Phosphoric Acid 4.4 KH2PO«4 — Potassium phosphate monobasic 4.5 © ACN-— Acetonitrile 4.6 CofA — Certificate of Analysis 4.7. H20- Millipore Water [SOP Standard Operating Procedure SOP No Rev Page Salidroside Determination by HPLC using UV/VIS D-758 1 2 of 6 Spectroscopy 4.8 Salidroside — 2-(4-hydroxypheny])ethyl B-D-glucopyranoside 5.0 References 5.1 | USP43-NF38 USP Monograph for Rhodiola rosea 6.0 Supplies 6.1 Chemicals: All reagents are HPLC grade or better. ore H20 oe ee ACN 6.1.3 H3PO4 6.1.4 KH2PO4 6.1.5 Methanol 6.1.6 Salidroside reference standard 6.2 Glassware 6.2.1 HPLC vials, 12mm x 32mm with screw cap enclosures with septa 622 Scintillation Vials 6.2.3 1L Mobile Phase Container 6.2.4 50mL Volumetric Flask 6.2.5 100mL Volumetric Flask 6.3. Disposables 6.3.1 10mL Pipette Tips 6.3.2 ImL Pipette Tips 6:3:3 200uL Pipette Tips 6.3.4 1.5mL microfuge tubes 6.3.5 16mL Test Tubes 6.3.6 Disposable Plastic Luer Lock Syringe — 3mL, 6mL, or 10mL [SOP Standard Operating Procedure SOP No Rev Page Salidroside Determination by HPLC using UV/VIS D-758 1 3 of 6 Spectroscopy 6.3.7 Nylon Syringe Filters, 0.2um 6.3.8 Weigh paper 6.4 Equipment 6.4.1 Suitable gradient HPLC system consisting of a pump, autosampler, column oven and UV detector with a chromatographic data handling system 6.4.2 Analytical Balance 6.4.3 Ultrasonic bath 6.4.4 Vortex 6.4.5 Stir Plate 6.4.6 Eppendorf Centrifuge 6.4.7 10mL Pipette 6.4.8 ImL Pipette 6.4.9 200uL Pipette 7.0 Preparation of Mobile Phase, Dissolution Buffer, Samples, and Standards Tal Mobile Phase A — H2O0 G2 Mobile Phase B —- ACN 7.3 Diluent—100% methanol 7.4 Working Standard Preparation 7.4.1 Accurately weigh and transfer about 30 mg of Salidroside reference standard into a 100-mL volumetric flask. 7.4.2 Dissolve in and QS with Diluent. is Sample Preparation 7.5.1 Raw materials can be dissolved in Diluent at any volume starting from 50 mL and any weight greater than the minimum weight of the analytical balance. [SOP Standard Operating Procedure SOP No Rev Page Salidroside Determination by HPLC using UV/VIS D-758 1 4 of 6 Spectroscopy 7.5.2 Accurately weigh and transfer an amount of sample sufficient to generate a salidroside concentration of 0.3 mg/mL into a suitably sized volumetric flask. 7.5.3 Dilute to volume using Diluent, and sonicate for 10 minutes. 7.5.4 Before injection, insoluble matter should be removed via filtration using a 0.45um nylon syringe filter. Discard at least 0.5 mL of the filtrate before collecting a portion in an HPLC vial for analysis. 7.5.4.1 Alternatively, samples and standards can also be centrifuged at 5000 RPM for 3 minutes in an Eppendorf centrifuge to pellet insoluble matter. 7.5.5 For raw materials or finished products being analyzed for the first time using this method, in-process verification is required to demonstrate spectral purity and extraction efficiency before the method can be implemented. 8.0 Test Conditions 8.1 Gradient Time MA %B Gradient Type 0.00 94 6 Initial 6.00 83 17 Linear 7.00 80.3 19.7 Linear 9.00 80.3 197 0 10.0 0 100 Linear 12.0 94 6 Linear 17.0 94 6 0 8.2 Column — ZORBAX Eclipse AAA. 3.5 um, 120A, 4.6 X 250 mm, or equivalent 8.3 Flow Rate — 1.0 mL/min 8.4 UV Detection — 205 nm 8.5 3D Spectral Range — 210 nm — 320 nm [SOP Standard Operating Procedure SOP No Rev Page Salidroside Determination by HPLC using UV/VIS D-758 5 of6 Spectroscopy 8.6 Injection Volume — 1 wL 8.7. Column Temperature — 40 °C 8.8 | Recommended Sequence 8.8.1 Make at least 2 injections of the diluent. 8.8.2 Make five (5) injections of Standard Solution. 8.8.3 Make a single injection of each Sample Preparation. 8.8.4 Make a single injection of the Standard Solution after every six (6) samples and at the end of the run. 8.9 System Suitability Requirements 8.9.1 The %RSD of five (5) injections of Working Standard is NMT 2%. 8.9.2 The %RSD of all injections of Working Standard is NMT 3%. 8.9.3 The spectral match over the range 210 nm — 320 nm is NLT 900. 8.9.4 The retention time of the sample is within 0.3 min of the standard. 8.10 Column Wash and Storage 8.10.1 Rinse and store the column with H20/ACN (50/50). 9.0 Calculations 9.1 Example calculations for determining finished product % label or raw material % purity 91.1 % assay = ~ x asWtetra d*XTP yg SV Ry LSS PPX 100 Vsta SA ° LA Ry Sample peak area Rg Mean standard peak area Wtsq Weight of reference standard in mg V;tq Volume of the standard preparation accounting for dilutions in mL P Purity of the reference standard in decimal format [SOP Standard Operating Procedure SOP No Rev Page Salidroside Determination by HPLC using UV/VIS D-758 6 of6 Spectroscopy SA Sample amount in mg (solids) or mL (liquids) Von. Volume of the sample preparation accounting for dilutions in mL SS Serving size: Weight of a single dosage unit in mg for tablets and capsules, volume of a single serving from the theoretical formula in mL for liquids, or 1 for raw materials. LA Label amount in mg per dose or | for raw materials 10.0 Revision History | Rev | Date | Description of Changes | CCR # | By | |-----|----------|------------------------|-------|----| | 0 | 01/02/19 | New N/A J. Maignan Update for consistency with current practices and clarity. Fix standard concentration to match USP since linearity is not validated. 04/11/22 Add system suitability section. Add recommended sequence. Add CC-22-0175 S. Sassman column wash and storage. Add requirement for spectral match and set range. | - | - |